通过针对最小残留疾病来改变卵巢癌护理

Amir A Jazaeri1, Rachel Grisham2, Anne Knisely1

  • 1University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Med (New York, N.Y.)
|November 11, 2023
PubMed
概括

晚期卵巢癌的治愈率仍然停滞不前. 这项研究探讨了最小残留疾病,以寻找治疗不可治愈的复发的新疗法.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K